Insulin therapy in type II diabetes.

[1]  R. Holman,et al.  Optimizing Blood Glucose Control in Type 2 Diabetes: an Approach Based on Fasting Blood Glucose Measurements , 1988, Diabetic medicine : a journal of the British Diabetic Association.

[2]  H. Yki-Järvinen,et al.  Clinical benefits and mechanisms of a sustained response to intermittent insulin therapy in type 2 diabetic patients with secondary drug failure. , 1988, The American journal of medicine.

[3]  S. Schwartz,et al.  Effects of short-term insulin therapy upon therapeutic response to glipizide. , 1987, The American journal of medicine.

[4]  R. Holman,et al.  Sulphonylurea Failure in Type 2 Diabetes: Treatment with a Basal Insulin Supplement , 1987, Diabetic medicine : a journal of the British Diabetic Association.

[5]  S. Efendić,et al.  Glyburide Decreases Insulin Requirement, Increases (β-Cell Response to Mixed Meal, and Does Not Affect Insulin Sensitivity: Effects of Short- and Long-Term Combined Treatment in Secondary Failure to Sulfonylurea , 1987, Diabetes Care.

[6]  M. Riddle.  NEW TACTICS FOR TYPE 2 DIABETES: REGIMENS BASED ON INTERMEDIATE-ACTING INSULIN TAKEN AT BEDTIME , 1985, The Lancet.

[7]  R. Holman,et al.  THE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES , 1981, Clinical endocrinology.

[8]  P. Bennett,et al.  DEVELOPMENT OF RETINOPATHY AND PROTEINURIA IN RELATION TO PLASMA-GLUCOSE CONCENTRATIONS IN PIMA INDIANS , 1980, The Lancet.

[9]  R. Turner,et al.  Control of Maturity-Onset Diabetes by Monitoring Fasting Blood Glucose and Body Weight , 1980, Diabetes Care.

[10]  M. Shipley,et al.  CORONARY-HEART-DISEASE RISK AND IMPAIRED GLUCOSE TOLERANCE The Whitehall Study , 1980, The Lancet.

[11]  H. Keen,et al.  HYPERGLYCÆMIA AND DIABETES MELLITUS , 1976, The Lancet.